Several screening studies have indicated an increased prevalence of celiac disease (CD) among individuals with autoimmune thyroid disease (ATD), but estimates have varied substantially.
Objective:
The aim of this study was to examine the prevalence of CD in patients with ATD.
Method:
A systematic review was conducted of articles published in PubMed Medline or EMBASE until September 2015. Non-English papers with English-language abstracts were also included, as were research abstracts without full text available when relevant data were included in the abstract. Search terms included “celiac disease” combined with “hypothyroidism” or “hyperthyroidism” or “thyroid disease.” Fixed-effects inverse variance-weighted models were used. Meta-regression was used to examine heterogeneity in subgroups.
Results:
A pooled analysis, based on 6024 ATD patients, found a prevalence of biopsy-confirmed CD of 1.6% [confidence interval (CI) 1.3–1.9%]. Heterogeneity was large (I2 = 70.7%). The prevalence was higher in children with ATD (6.2% [CI 4.0–8.4%]) than it was in adults (2.7%) or in studies examining both adults and children (1.0%). CD was also more prevalent in hyperthyroidism (2.6% [CI 0.7–4.4%]) than it was in hypothyroidism (1.4% [CI 1.0–1.9%]).
Conclusions:
About 1/62 patients with ATD have biopsy-verified CD. It is argued that patients with ATD should be screened for CD, given this increased prevalence.
Get full access to this article
View all access options for this article.
References
1.
LudvigssonJF, LefflerDA, BaiJC, BiagiF, FasanoA, GreenPH, HadjivassiliouM, KaukinenK, KellyCP, LeonardJN, LundinKE, MurrayJA, SandersDS, WalkerMM, ZingoneF, CiacciC. 2013. The Oslo definitions for coeliac disease and related terms. Gut, 62:43–52.
2.
MustalahtiK, CatassiC, ReunanenA, FabianiE, HeierM, McMillanS, MurrayL, MetzgerMH, GasparinM, BraviE, MakiM. 2010. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med, 42:587–595.
3.
AjjanRA, WeetmanAP. 2015. The pathogenesis of Hashimoto's thyroiditis: further developments in our understanding. Horm Metab Res, 47:702–710.
4.
VaidyaB, PearceSH. 2014. Diagnosis and management of thyrotoxicosis. BMJ, 349:g5128.
5.
TomerY, BlackardJT, AkenoN. 2007. Interferon alpha treatment and thyroid dysfunction. Endocrinol Metab Clin North Am, 36:1051–1066; x–xi.
6.
VasudevanA, LubelJS. 2015. New-onset of celiac disease during interferon-based therapy for hepatitis C. Gastroenterol Rep, 3:83–85.
7.
ElfstromP, MontgomerySM, KampeO, EkbomA, LudvigssonJF. 2008. Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab, 93:3915–3921.
8.
FanciulliG, TomasiPA, CaucciF, LaiE, SanciuF, DelitalaG. 2005. Screening for celiac disease in patients with autoimmune thyroid disease: from research studies to daily clinical practice. Ann Ital Med Int, 20:39–44.
9.
De MartinoL, Di DonatoI, AlfanoS, D'AcunzoI, Di PintoR, CapalboD, SalernoM. 2014. Prevalence of additional autoimmune diseases in autoimmune's thyroiditis children and their first-and second-degree relatives: results from a large, single-center study. Horm Res Paediatr, 82:460.
10.
ChawlaA, SattarN, LazareF, WilsonT, LaneA, GarciaM. 2009. Prevalence of tissue transglutaminase IGA antibody and celiac disease in children with autoimmune thyroid disease. J Pediatr Gastroenterol Nutr, 49:E13–E14.
11.
LarizzaD, CalcaterraV, De GiacomoC, De SilvestriA, AstiM, BadulliC, AutelliM, CoslovichE, MartinettiM. 2001. Celiac disease in children with autoimmune thyroid disease. J Pediatr, 139:738–740.
12.
JiskraJ, LimanovaZ, VanickovaZ, KocnaP. 2003. IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiol Res, 52:79–88.
13.
WieboltJ, AchterberghR, den BoerA, van der LeijS, MarschE, SuelmannB, de VriesR, van HaeftenTW. 2011. Clustering of additional autoimmunity behaves differently in Hashimoto's patients compared with Graves’ patients. Eur J Endocrinol, 164:789–794.
StagiS, ManoniC, CecchiC, ChiarelliF, de MartinoM. 2011. Increased risk of coeliac disease in patients with congenital hypothyroidism. Horm Res Paediatr, 76:186–192.
16.
MeloFM, CavalcantiMS, SantosSB, LopesAK, OliveiraFA. 2005. [Association between serum markers for celiac and thyroid autoimmune diseases]. Arq Bras Endocrinol Metabol, 49:542–547.
17.
MarwahaRK, GargMK, TandonN, KanwarR, NarangA, SastryA, SaberwalA, BhadraK. 2013. Glutamic acid decarboxylase (anti-GAD) and tissue transglutaminase (anti-TTG) antibodies in patients with thyroid autoimmunity. Indian J Med Res, 137:82–86.
18.
OzsuE, MutluRGY, CizmeciF, HatunS. 2011. Characteristics of our patients with Hashimoto thyroiditis. Turk Pediatri Arsivi, 46:252–255.
19.
BoelaertK, NewbyPR, SimmondsMJ, HolderRL, Carr-SmithJD, HewardJM, ManjiN, AllahabadiaA, ArmitageM, ChatterjeeKV, LazarusJH, PearceSH, VaidyaB, GoughSC, FranklynJA. 2010. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med, 123:183.e1–9.
20.
IuorioR, MercuriV, BarbaruloF, D'AmicoT, MeccaN, BassottiG, PietrobonoD, GargiuloP, PicarelliA. 2007. Prevalence of celiac disease in patients with autoimmune thyroiditis. Minerva Endocrinol, 32:239–243.
21.
TeixeiraLM, NisiharaR, UtiyamaSR, BemRS, MarcattoC, BertolazoM, CarvalhoGA. 2014. Screening of celiac disease in patients with autoimmune thyroid disease from Southern Brazil. Arq Bras Endocrinol Metabol, 58:625–629.
22.
Mallea-GilS, AparicioM, BertiniK, RidruejoC, ErcoliV, GimenezS, AndrushA, Cedeno-ArauzV, Perez-MartinezS, AldabeN, IriarteM, GalarzaP, PeruscoA, RovetoS, RiveroE, BallarinoC. 2012. Association between autoimmune thyroid diseases and celiac disease. The tip of the iceberg of the autoimmune polyendocrine syndrome?. Endocr Rev, 33:M-407.
23.
VenturaA, RonsoniMF, ShiozawaMBC, Dantas-CorreaEB, CanalliMHBS, de Lucca SchiavonL, Narciso-SchiavonJL. 2014. Prevalence and clinical features of celiac disease in patients with autoimmune thyroiditis: cross-sectional study. Sao Paulo Med J, 132:360–367.
MehrdadM, Mansour-GhanaeiF, MohammadiF, JoukarF, DodangehS, Mansour-GhanaeiR. 2012. Frequency of celiac disease in patients with hypothyroidism. J Thyroid Res, 2012:201538.
BertiI, TrevisiolC, TommasiniA, CittaA, NeriE, GeattiO, GiammariniA, VenturaA, NotT. 2000. Usefulness of screening program for celiac disease in autoimmune thyroiditis. Dig Dis Sci, 45:403–406.
28.
MeloniGF, TomasiPA, BertoncelliA, FanciulliG, DelitalaG, MeloniT. 2001. Prevalence of silent celiac disease in patients with autoimmune thyroiditis from Northern Sardinia. J Endocrinol Invest, 24:298–302.
29.
VoltaU, RavagliaG, GranitoA, FortiP, MaioliF, PetroliniN, ZoliM, BianchiFB. 2001. Coeliac disease in patients with autoimmune thyroiditis. Digestion, 64:61–65.
30.
RavagliaG, FortiP, MaioliF, VoltaU, ArnoneG, PantieriG, TalericoT, MuscariA, ZoliM. 2003. Increased prevalence of coeliac disease in autoimmune thyroiditis is restricted to aged patients. Exp Gerontol, 38:589–595.
31.
SpadaccinoAC, BassoD, ChiarelliS, AlbergoniMP, D'OdoricoA, PlebaniM, PediniB, LazzarottoF, BetterleC. 2008. Celiac disease in North Italian patients with autoimmune thyroid diseases. Autoimmunity, 41:116–121.
32.
CuocoL, CertoM, JorizzoRA, De VitisI, TursiA, PapaA, De MarinisL, FedeliP, FedeliG, GasbarriniG. 1999. Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders. Ital J Gastroenterol Hepatol, 31:283–287.
33.
ValentinoR, SavastanoS, TommaselliAP, DoratoM, ScarpittaMT, GiganteM, MicilloM, PaparoF, PetroneE, LombardiG, TronconeR. 1999. Prevalence of coeliac disease in patients with thyroid autoimmunity. Horm Res, 51:124–127.
34.
MainardiE, MontanelliA, DottiM, NanoR, MoscatoG. 2002. Thyroid-related autoantibodies and celiac disease: a role for a gluten- free diet?. J Clin Gastroenterol, 35:245–248.
35.
FarahidOH, KhawajaN, ShennakMM, BatiehaA, El-KhateebM, AjlouniK. 2014. Prevalence of coeliac disease among adult patients with autoimmune hypothyroidism in Jordan. East Mediterr Health J, 20:51–55.
36.
HadithiM, de BoerH, MeijerJW, WillekensF, KerckhaertJA, HeijmansR, PenaAS, StehouwerCD, MulderCJ. 2007. Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. World J Gastroenterol, 13:1715–1722.
37.
KaczorowskaM, AndrzejewskaM, BaczykI, NiedzielaM, SzczepanskiM, PonichteraJ. 2006. The prevalence of celiac disease among children with autoimmune thyroid disease. Pediatria Wspolczesna, 8:222–227.
38.
Grzenda-AdamekZ, Kalicka-KasperczykA, StarzykJ, FyderekK. 2008. Is screening test for celiac disease in children with autoimmune thyroid disease justified?. Pediatria Wspolczesna, 10:125–128.
39.
MankaiA, Chadli-ChaiebM, SaadF, Ghedira-BesbesL, OuertaniM, SfarH, LimemM, Ben AbdessalemM, JeddiM, ChaiebL, GhediraI. 2006. Screening for celiac disease in Tunisian patients with Graves’ disease using anti-endomysium and anti-tissue transglutaminase antibodies. Gastroenterol Clin Biol, 30:961–964.
40.
GuliterS, YakaryilmazF, OzkurtZ, ErsoyR, UcardagD, CaglayanO, AtasoyP. 2007. Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population. World J Gastroenterol, 13:1599–1601.
41.
SariS, YesilkayaE, EgritasO, BideciA, DalgicB. 2009. Prevalence of celiac disease in Turkish children with autoimmune thyroiditis. Dig Dis Sci, 54:830–832.
42.
Ch'ngCL, BiswasM, BentonA, JonesMK, KinghamJG. 2005. Prospective screening for coeliac disease in patients with Graves’ hyperthyroidism using anti-gliadin and tissue transglutaminase antibodies. Clin Endocrinol (Oxf), 62:303–306.
43.
SattarN, LazareF, KacerM, Aguayo-FigueroaL, DesikanV, GarciaM, LaneA, ChawlaA, WilsonT. 2011. Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease. J Pediatr, 158:272–275.e271.
44.
ZubarikR, NathanM, VahoraH, GangulyEK, VecchioJ. 2014. Hypothyroid patients requiring elevated doses of levothyroxine to maintain a euthyroid state should be tested for celiac disease (CD). Gastroenterology, 146:S-468.
45.
MarshMN. 1992. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (“celiac sprue”). Gastroenterology, 102:330–354.
46.
DubeC, RostomA, SyR, CranneyA, SaloojeeN, GarrittyC, SampsonM, ZhangL, YazdiF, MamaladzeV, PanI, MacneilJ, MackD, PatelD, MoherD. 2005. The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review. Gastroenterology, 128:S57–67.
47.
Blood Pressure Lowering Treatment Trialists C, SundstromJ, ArimaH, WoodwardM, JacksonR, KarmaliK, Lloyd-JonesD, BaigentC, EmbersonJ, RahimiK, MacMahonS, PatelA, PerkovicV, TurnbullF, NealB. 2014. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet, 384:591–598.
48.
ErtekinV, SelimogluMA, KardasF, AktasE. 2005. Prevalence of celiac disease in Turkish children. J Clin Gastroenterol, 39:689–691.
49.
MoraM, LitwinN, Toca MdelC, AzconaMI, Solis NeffaR, BattistonF, SolaeguiM, OrtizG, WagenerM, OliveraJ, MarchisoneS, OropezaG, BastianelliC, GonzalezA, RezzonicoG. 2012. Prevalence of celiac disease: multicentric trial among pediatric population from five urban districts in Argentina. Arch Argent Pediatr, 110:490–496.
50.
Rubio-TapiaA, LudvigssonJF, BrantnerTL, MurrayJA, EverhartJE. 2012. The prevalence of celiac disease in the United States. Am J Gastroenterol, 107:1538–1544; quiz 1537, 1545.
51.
SchweizerJJ, von BlombergBM, Bueno-de MesquitaHB, MearinML. 2004. Coeliac disease in The Netherlands. Scand J Gastroenterol, 39:359–364.
52.
Szaflarska-PoplawskaA, ParzeckaM, MullerL, PlacekW. 2009. Screening for celiac disease in Poland. Med Sci Monit, 15:PH7–11.
53.
Ben HarizM, Kallel-SellamiM, KallelL, LahmerA, HaliouiS, BouraouiS, LaaterA, SlitiA, MahjoubA, ZouariB, MakniS, MaherziA. 2007. Prevalence of celiac disease in Tunisia: mass-screening study in schoolchildren. Eur J Gastroenterol Hepatol, 19:687–694.
54.
AkbariMR, MohammadkhaniA, FakheriH, Javad ZahediM, ShahbazkhaniB, NouraieM, SotoudehM, ShakeriR, MalekzadehR. 2006. Screening of the adult population in Iran for coeliac disease: comparison of the tissue-transglutaminase antibody and anti-endomysial antibody tests. Eur J Gastroenterol Hepatol, 18:1181–1186.
55.
OliveiraRP, SdepanianVL, BarretoJA, CortezAJ, CarvalhoFO, BordinJO, de Camargo SoaresMA, da Silva PatricioFR, KawakamiE, de MoraisMB, Fagundes-NetoU. 2007. High prevalence of celiac disease in Brazilian blood donor volunteers based on screening by IgA antitissue transglutaminase antibody. Eur J Gastroenterol Hepatol, 19:43–49.
56.
NusierMK, BrodtkorbHK, ReinSE, OdehA, RadaidehAM, KlunglandH. 2010. Serological screening for celiac disease in schoolchildren in Jordan. Is height and weight affected when seropositive?. Ital J Pediatr, 36:16.
57.
OlenO, BihagenE, RasmussenF, LudvigssonJF. 2012. Socioeconomic position and education in patients with coeliac disease. Dig Liver Dis, 44:471–476.
58.
ZingoneF, WestJ, CrooksCJ, FlemingKM, CardTR, CiacciC, TataLJ. 2015. Socioeconomic variation in the incidence of childhood coeliac disease in the UK. Arch Dis Child, 100:466–473.
59.
ElfstromP, SundstromJ, LudvigssonJF. 2014. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol Ther, 40:1123–1132.
60.
ElfstromP, MontgomerySM, KampeO, EkbomA, LudvigssonJF. 2007. Risk of primary adrenal insufficiency in patients with celiac disease. J Clin Endocrinol Metab, 92:3595–3598.
61.
WelanderA, SundelinB, ForedM, LudvigssonJF. 2013. Increased risk of IgA nephropathy among individuals with celiac disease. J Clin Gastroenterol, 47:678–683.
62.
NgJP, GreenST, LamDC, ShahriariS. 1988. Coeliac disease and pernicious anaemia. Postgrad Med J, 64:889–890.
63.
VenturaA, NeriE, UghiC, LeopaldiA, CittaA, NotT. 2000. Gluten-dependent diabetes-related and thyroid-related autoantibodies in patients with celiac disease. J Pediatr, 137:263–265.
64.
RostomA, DubeC, CranneyA, SaloojeeN, SyR, GarrittyC, SampsonM, ZhangL, YazdiF, MamaladzeV, PanI, MacNeilJ, MackD, PatelD, MoherD. 2005. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology, 128:S38–46.
WalkerMM, MurrayJA. 2010. An update in the diagnosis of coeliac disease. Histopathology, 59:166–179.
67.
HusbyS, KoletzkoS, Korponay-SzaboIR, MearinML, PhillipsA, ShamirR, TronconeR, GiersiepenK, BranskiD, CatassiC, LelgemanM, MakiM, Ribes-KoninckxC, VenturaA, ZimmerKP. 2012. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr, 54:136–160.
68.
Rubio-TapiaA, HillID, KellyCP, CalderwoodAH, MurrayJA. 2013. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol, 108:656–676; quiz 677.
69.
LudvigssonJF, BaiJC, BiagiF, CardTR, CiacciC, CiclitiraPJ, GreenPH, HadjivassiliouM, HoldowayA, van HeelDA, KaukinenK, LefflerDA, LeonardJN, LundinKE, McGoughN, DavidsonM, MurrayJA, SwiftGL, WalkerMM, ZingoneF, SandersDS, Authors of the BSGCDGDG. 2014. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut, 63:1210–1228.
70.
LudvigssonJF, CardTR, KaukinenK, BaiJ, ZingoneF, SandersDS, MurrayJA. 2015. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J, 3:106–120.
71.
LiberatiA, AltmanDG, TetzlaffJ, MulrowC, GotzschePC, IoannidisJP, ClarkeM, DevereauxPJ, KleijnenJ, MoherD. 2009. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ, 339:b2700.
WierdsmaNJ, van Bokhorst-de van der SchuerenMA, BerkenpasM, MulderCJ, van BodegravenAA. 2013. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients, 5:3975–3992.
74.
KhashanAS, HenriksenTB, MortensenPB, McNameeR, McCarthyFP, PedersenMG, KennyLC. 2010. The impact of maternal celiac disease on birthweight and preterm birth: a Danish population-based cohort study. Hum Reprod, 25:528–534.
75.
CosnesJ, CellierC, ViolaS, ColombelJF, MichaudL, SarlesJ, HugotJP, GiniesJL, DabadieA, MouterdeO, AllezM, Nion-LarmurierI. 2008. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol, 6:753–758.
76.
PaavolaA, KurppaK, UkkolaA, CollinP, LahdeahoML, HuhtalaH, MakiM, KaukinenK. 2012. Gastrointestinal symptoms and quality of life in screen-detected celiac disease. Dig Liver Dis, 44:814–818.
77.
LudvigssonJF, MontgomerySM, EkbomA. 2005. Celiac disease and risk of adverse fetal outcome: a population-based cohort study. Gastroenterology, 129:454–463.
78.
LebwohlB, GranathF, EkbomA, SmedbyKE, MurrayJA, NeugutAI, GreenPH, LudvigssonJF. 2013. Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med, 159:169–175.
UkkolaA, MakiM, KurppaK, CollinP, HuhtalaH, KekkonenL, KaukinenK. 2011. Diet improves perception of health and well-being in symptomatic, but not asymptomatic, patients with celiac disease. Clin Gastroenterol Hepatol, 9:118–123.
81.
KyriacouA, McLaughlinJ, SyedAA. 2015. Thyroid disorders and gastrointestinal and liver dysfunction: a state of the art review. Eur J Intern Med, 26:563–571.
82.
HershcoviciT, LeshnoM, GoldinE, ShamirR, IsraeliE. 2010. Cost effectiveness of mass screening for coeliac disease is determined by time-delay to diagnosis and quality of life on a gluten-free diet. Aliment Pharmacol Ther, 31:901–910.
83.
ShamirR, HernellO, LeshnoM. 2006. Cost-effectiveness analysis of screening for celiac disease in the adult population. Med Decis Making, 26:282–293.
84.
YangJJ, ThanataveeratA, GreenPH, LebwohlB. 2015. Cost effectiveness of routine duodenal biopsy analysis for celiac disease during endoscopy for gastroesophageal reflux. Clin Gastroenterol Hepatol, 13:1437–1443.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
